Steven Ashley Couldwell
Director
medicine
Tissue Regenix Group PLC
Germany
Biography
Steven Ashley Couldwell has been appointed as Non-Executive Director of Tissue Regenix Group PLC., effective July 17, 2013. Steven Couldwell has a proven international track record in driving revenues and profit growth in both the medical device and CRO industries. With over 14 years of senior management experience, Steven is currently Vice President and Head of Global Biosurgery at Sanofi, which has revenues of approximately $750m. Steven was also formerly Vice President and General Manager of Covance Laboratories Europe and worked for Smith & Nephew for almost 20 years in a number of roles including President Orthopaedics (Europe) and Senior VP Sales and Marketing for Smith & Nephew’s Advanced Wound Management business.
Research Interest
orthopaedics business management
